Lupin Limited has informed the Exchange regarding a press release dated Jun 07, 2025, titled "Lupin Receives Tentative Approval from U.S. FDA for Oxcarbazepine ER Tablets".
Lupin Limited has informed the Exchange regarding a press release dated Jun 07, 2025, titled "Lupin Receives Tentative Approval from U.S. FDA for Oxcarbazepine ER Tablets".